REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,261,236 | -59.0% | 1,200 | -65.7% | 0.04% | -83.0% |
| Q4 2023 | $3,074,015 | +6.7% | 3,500 | 0.0% | 0.26% | +99.2% |
| Q3 2023 | $2,880,360 | +133.7% | 3,500 | +133.3% | 0.13% | +118.0% |
| Q1 2023 | $1,232,505 | -77.2% | 1,500 | -80.0% | 0.06% | -79.6% |
| Q4 2022 | $5,411,175 | – | 7,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 98 | $4,785,000 | 0.40% |
| IMC-Chicago, LLC | 51,300 | $25,049,000 | 0.05% |
| SIMPLEX TRADING, LLC | 480 | $23,437,000 | 0.04% |
| Focused Wealth Management, Inc | 6,400 | $30,000 | 0.01% |
| SG Americas Securities, LLC | 35,000 | $642,000 | 0.01% |
| JPMORGAN CHASE & CO | 36,500 | $17,823,000 | 0.00% |
| Allianz Asset Management GmbH | 4,800 | $2,344,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 200 | $98,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |